No inhibition of IL-27 signaling by soluble gp130
- 2 December 2004
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 326 (4) , 724-728
- https://doi.org/10.1016/j.bbrc.2004.11.098
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- TGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-SignalingImmunity, 2004
- Understanding the Pro- and Anti-Inflammatory Properties of IL-27The Journal of Immunology, 2004
- WSX-1 and Glycoprotein 130 Constitute a Signal-Transducing Receptor for IL-27The Journal of Immunology, 2004
- IL-27, a Heterodimeric Cytokine Composed of EBI3 and p28 Protein, Induces Proliferation of Naive CD4+ T CellsImmunity, 2002
- WSX-1 Is Required for the Initiation of Th1 Responses and Resistance to L. major InfectionImmunity, 2001
- Soluble gp130 is the natural inhibitor of soluble interleukin‐6 receptor transsignaling responsesEuropean Journal of Biochemistry, 2001
- Development of Th1-type immune responses requires the type I cytokine receptor TCCRNature, 2000
- Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivoNature Medicine, 2000
- gp130 AND THE INTERLEUKIN-6 FAMILY OF CYTOKINESAnnual Review of Immunology, 1997
- Soluble receptors for cytokines and growth factors: generation and biological functionBiochemical Journal, 1994